Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2012	FY 2011
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2012	Dec 31, 2011
Pharmaceutical Division			71.32B	51.56B	47.09B	14.59B	-
Pharmaceutical Division Growth			38.31%	9.50%	222.85%	-	-
Unallocated Adjustment			-	-	-68.45M	-	-
Cosmetics Division			-	-	2.15B	841.33M	-
Cosmetics Division Growth			-	-	155.96%	-	-
Mining Division			-	-	8.39B	28.16B	-
Mining Division Growth			-	-	-70.23%	-	-
Semiconductor Equipment and Services			-	-	-	-	44.95B
Semiconductor Equipment and Services Growth			-	-	-	-	-2.28%
Total			71.32B	51.56B	57.56B	43.59B	44.95B
Total Growth			38.31%	-10.42%	32.04%	-3.03%	-2.28%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2012	FY 2011
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2012	Dec 31, 2011
Korea			69.79B	48.26B	52.33B	19.60B	9.27B
Korea Growth			44.62%	-7.79%	167.04%	111.43%	-5.80%
Japan			264.12M	77.82M	2.06B	21.35B	29.11B
Japan Growth			239.40%	-96.23%	-90.33%	-26.66%	-5.45%
People's Republic of China			886.35M	921.12M	879.14M	1.93B	5.74B
People's Republic of China Growth			-3.78%	4.78%	-54.49%	-66.33%	38.34%
Russia			277.09M	213.40M	419.11M	-	-
Russia Growth			29.84%	-49.08%	-	-	-
Other			1.23B	2.08B	1.86B	482.31M	259.76M
Other Growth			-41.10%	11.83%	286.18%	85.68%	-57.68%
Vietnam			149.27M	13.55M	263.00K	228.90M	576.46M
Vietnam Growth			1001.45%	5052.85%	-99.89%	-60.29%	-6.12%
Total			72.59B	51.56B	57.56B	43.59B	44.95B
Total Growth			40.78%	-10.42%	32.04%	-3.03%	-2.28%

Source: S&P Global Market Intelligence.